期刊文献+

胃上皮异型增生并结肠及小肠性化生中PCNA、P53蛋白和Survivin的表达及意义 被引量:10

Expression and significance of PCNA,P53 protein and Survivin in gastric epithelial dysplasia with colonic and small intestinal metaplasia
在线阅读 下载PDF
导出
摘要 目的检测胃上皮异型增生上皮并不同肠上皮化生组织中PCNA、P53蛋白和生存素(survivin)的表达及意义。方法应用组织化学法和免疫组织化学SP法检测44例结肠性化生(其中低度异型增生27例,高度异型增生17例)和51例小肠性化生(其中低度异型增生42例,高度异型增生9例)胃活检组织中PC-NA、P53蛋白和Survivin的表达。结果PCNA、P53蛋白和Survivin蛋白在胃上皮异型增生并结肠性化生与小肠性化生间的表达率差异有显著性。低度异型增生和高度异型增生间PCNA、P53蛋白和Survivin蛋白表达率差异有显著性。结论PCNA、P53和Survivin基因的改变不仅与肠上皮化生的类型有关,而且与胃上皮异型增生的程度密切相关。PCNA、P53和Survivin蛋白可作为判断胃异型增生上皮并肠上皮化生生物学行为有价值的指标。 [Objective] To investigate the expression of PCNA, P53 protein, and Survivin in gastric epithelial dysplasia with colonic and small intestinal metaplasia. [Methods] Immunohistoehemieal SP method was used to detect PCNA, P53 protein, and Survivin in 44 dysplasia with colonic intestinal metaplasia and 51 small intestinal metaplasia. [Results] The positive expression rates of PCNA, P53 protein, and Survivin had significant difference in two types of intestinal metaplasia, between low grade epithelial dysplasia and high grade epithelial dysplasia. [ Conelusion] The expression of PCNA, P53 protein, and Survivin had relation not only with types of intestinal metaplasia but also with different grade epithelial dysplasia. PCNA, P53 protein, and Survivin may be valuable markers in assessing biological behavior of gastric epithelial dysplasia with intestinal metaplasia.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2007年第3期279-281,共3页 China Journal of Modern Medicine
关键词 胃异型增生上皮 肠化生 PCNA P53蛋白 生存素 gastric epithelial dysplasia intestinal metaplasia PCNA P53 protein Survivin
  • 相关文献

参考文献5

二级参考文献24

  • 1毛杰,海健,舒衡平,苑著.凋亡抑制基因Survivin在乳腺癌组织中的表达与意义(英文)[J].中国现代医学杂志,2005,15(6):815-817. 被引量:11
  • 2张义范 张荫昌.胃癌[M].上海科学技术出版社,1987.69-70.
  • 3Rugge M, Leandro G, Farinati F,et al. Gastric epithelial dysplasia,How clinicopathologic background relates to management. Cancer,1995,76 : 376-382.
  • 4Rugge M, Farinati F, Baffa R, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a muhicenter prospective followup study. Gastroenterology, 1994,107 : 1288-1296.
  • 5Lansdown M, Quirke P, Dixon MF, et al. High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut , 1990,31 :977-983.
  • 6Farinati F, Rugge M, Di Mario F, et al. Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients: A prospective study. Endoscopy, 1993, 25:261-264.
  • 7Schlemper R J, Itabashi M, Kato Y, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet,1997, 349: 1725-1729.
  • 8Plummer M, Buiatti E, Lopez G, et al. Histological diagnosis of precancerous lesions of the stomach : a reliability study. Int J Epidemiol.1997,26:716-720.
  • 9ADIDA C,CROTFY PL,MC GRATH J,et al.Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation[J].Am J Pathol,1998,152:43-49.
  • 10SARELA AI,MACADAM RC,FARMERY SM,et al.Expression of the antiapoptosis gene,survivin,Predicts death from recurrent colorectal carcinoma[J].Gut,2000,46:645-650.

共引文献19

同被引文献93

引证文献10

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部